BACKGROUND: Each year, a large number of individuals in Australia are deferred from donating blood. A deferral may have a negative impact on donor satisfaction and subsequent word-of-mouth communication. The Australian Red Cross Blood Service (the Blood Service) is, therefore, investigating options for managing service interactions with deferred donors to maintain positive relationships. While public research institutes in Australia have established independent research donor registries, other countries provide programmes allowing deferred donors to donate blood for research via blood collection agencies. This study examined attitudes towards donating blood for research use in a sample of permanently deferred Australian donors. MATERIALS AND METHODS: Donors permanently deferred because of a risk of variant Creutzfeldt-Jakob disease (n=449) completed a postal survey that examined attitudes towards research donation. RESULTS: The majority of participants were interested in donating blood for research (96%), and joining a registry of research donors (93%). Participants preferred to donate for transfusion or clinical research, and were willing to travel large distances. Results indicated that positive attitudes towards the Blood Service would be extended if the opportunity to donate blood was provided. These findings indicate a desire for continued engagement with the Blood Service despite deferral. DISCUSSION: Donating blood for research is a potential way of maintaining positive relationships with permanently deferred donors which also benefits the health research community. Through maintaining positive relationships with deferred donors, positive word-of-mouth activity can be stimulated. Further work is needed to determine the feasibility of implementing research donation through the Blood Service in Australia.
BACKGROUND: Each year, a large number of individuals in Australia are deferred from donating blood. A deferral may have a negative impact on donor satisfaction and subsequent word-of-mouth communication. The Australian Red Cross Blood Service (the Blood Service) is, therefore, investigating options for managing service interactions with deferred donors to maintain positive relationships. While public research institutes in Australia have established independent research donor registries, other countries provide programmes allowing deferred donors to donate blood for research via blood collection agencies. This study examined attitudes towards donating blood for research use in a sample of permanently deferred Australian donors. MATERIALS AND METHODS: Donors permanently deferred because of a risk of variant Creutzfeldt-Jakob disease (n=449) completed a postal survey that examined attitudes towards research donation. RESULTS: The majority of participants were interested in donating blood for research (96%), and joining a registry of research donors (93%). Participants preferred to donate for transfusion or clinical research, and were willing to travel large distances. Results indicated that positive attitudes towards the Blood Service would be extended if the opportunity to donate blood was provided. These findings indicate a desire for continued engagement with the Blood Service despite deferral. DISCUSSION: Donating blood for research is a potential way of maintaining positive relationships with permanently deferred donors which also benefits the health research community. Through maintaining positive relationships with deferred donors, positive word-of-mouth activity can be stimulated. Further work is needed to determine the feasibility of implementing research donation through the Blood Service in Australia.
Authors: Rainer Seitz; Friedger von Auer; Johannes Blümel; Reinhard Burger; Anne Buschmann; Klaus Dietz; Margarethe Heiden; Walter E Hitzler; Horst Klamm; Thomas Kreil; Hans Kretzschmar; Micha Nübling; Ruth Offergeld; Georg Pauli; Volkmar Schottstedt; Peter Volkers; Inga Zerr Journal: Biologicals Date: 2007-02-21 Impact factor: 1.856
Authors: M Howard Tattum; Samantha Jones; Suvankar Pal; Azedeh Khalili-Shirazi; John Collinge; Graham S Jackson Journal: Transfusion Date: 2010-12 Impact factor: 3.157
Authors: Karin P H Lemmens; Robert A C Ruiter; Charles Abraham; Ingrid J T Veldhuizen; Herman P Schaalma Journal: Health Psychol Date: 2010-11 Impact factor: 4.267
Authors: R G Will; J W Ironside; M Zeidler; S N Cousens; K Estibeiro; A Alperovitch; S Poser; M Pocchiari; A Hofman; P G Smith Journal: Lancet Date: 1996-04-06 Impact factor: 79.321
Authors: A F Hill; R J Butterworth; S Joiner; G Jackson; M N Rossor; D J Thomas; A Frosh; N Tolley; J E Bell; M Spencer; A King; S Al-Sarraj; J W Ironside; P L Lantos; J Collinge Journal: Lancet Date: 1999-01-16 Impact factor: 79.321